Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Rheumatology News celebrates 20 years
News
Lilly calls it quits on baricitinib’s development for lupus
News
FDA approves risankizumab (Skyrizi) for psoriatic arthritis
News
Tofacitinib approved for new ankylosing spondylitis indication
News
Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indication
News
Axial spondyloarthritis survey raises importance of discussing treatment changes
News
Adalimumab biosimilar Cyltezo gets interchangeability designation
News
Temporary hold of mycophenolate helps immune response to SARS-CoV-2 vaccination
News
European agency recommends two new adalimumab biosimilars
News
Low RA flare rate reported after Pfizer COVID vaccination
News
NIH to study COVID vaccine booster in people with autoimmune disease
News
VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves
News
FDA warning letters target OTC cannabidiol product claims for pain relief
News
Dan Kastner wins Crafoord Prize in Polyarthritis
News
